Semaglutide PrIor to CathEeter Ablation in Patients With Atrial Fibrillation

Summary

To evaluate whether pre-treatment with semaglutide is superior to standard care in improving freedom from atrial fibrillation (AF) at 12 months following catheter ablation in patients with obesity and symptomatic AF undergoing first-time ablation.

Timeline

Start

2026-10

Primary completion

2029-04

Completion

2029-04

Drugs

Indications